Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2014

Dec 10, 2014

35119_dirs_2014-12-10_41ece644-4a23-4b0c-a142-6bcd8a7965ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2014-12-05

Reporting Person: Donini Oreola (Senior Vice President and CSO)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $1.56 2023-08-14 Common Stock (40000) Direct
Stock Option (Right to Buy) $2.01 2023-12-04 Common Stock (20000) Direct
Stock Option (Right to Buy) $1.50 2024-12-03 Common Stock (30000) Direct

Footnotes

F1: The stock option is vested as to 10,000 shares and vests as to the remainder at a rate of 2,500 shares on each three (3) month anniversary of August 15, 2013.

F2: The stock option is vested as to 5,000 shares and vests as to the remainder at a rate of 1,250 shares on each three (3) month anniversary of December 5, 2013.

F3: The stock option is vested as to 7,500 shares and vests as to the remainder at a rate of 1,875 shares on each three (3) month anniversary of December 4, 2014.